TUPEA04	HIV-1 infection: virus and host wrestle for control of the SUMOylation system	Poster exhibition	Understanding and targeting persistent HIV reservoirs
TUPEA03	Detection of intact HIV provirus in a microglia-enriched fraction of the CNS of a virally suppressed individual with HIV	Poster exhibition	Understanding and targeting persistent HIV reservoirs
TUPEA02	The effects of HIV-1 antigen expanded specific T cell therapy (HXTC) and vorinostat on persistent HIV-1 in people living with HIV on antiretroviral therapy	Poster exhibition	Understanding and targeting persistent HIV reservoirs
TUPEA01	The impact of B cell activation on HIV-1 binding and trans infection of CD4⁺ T cells	Poster exhibition	Understanding and targeting persistent HIV reservoirs
OALBX0205	Association of HIV pre-exposure prophylaxis (PrEP) use and bacterial sexually transmitted infections (bSTI) among men who have sex with men (MSM) and transgender women (TGW) in HVTN 704/HPTN 085	Oral abstract session with live Q&A	HIV prevention research
OALBX0204	Racial disparities in HIV incidence and PrEP non-adherence among gay and other men who have sex with men (MSM) and transgender women (TGW) using oral PrEP in Brazil: ImPrEP Study	Oral abstract session with live Q&A	HIV prevention research
OALBX0203	Initial PrEP product choice: results from the HPTN 084 open-label extension	Oral abstract session with live Q&A	HIV prevention research
OALBX0202	Positive Predictive Value of HIV Serological Tests in HPTN 084 Trial	Oral abstract session with live Q&A	HIV testing
OALBX0105	Socioeconomic support to improve completion of tuberculosis preventive therapy among adults starting HIV treatment in Tanzania: a quasi-cluster randomized trial	Oral abstract session with live Q&A	Integration of HIV services with other health and support services
OALBX0104	Sustained aviraemia in the absence of anti-retroviral therapy in male children following in utero vertical HIV transmission	Oral abstract session with live Q&A	Host immune responses, vaccines and immunotherapies